Oncology & Cancer

Margin-positive surgery still beneficial in pancreatic cancer

(HealthDay)—For patients with stage II pancreatic cancer, attempted surgery with margin-positive resection may offer survival benefit over chemotherapy alone, according to a study published online March 26 in the Journal ...

Medical research

Improving survival in pancreatic cancer

Nagoya University researchers and colleagues in Japan have uncovered a molecular pathway that enhances chemotherapy resistance in some pancreatic cancer patients. Targeting an RNA to interrupt its activity could improve patient ...

Oncology & Cancer

Research sheds new light on pancreatic cancer metastasis

With an overall survival rate of 9% for those diagnosed, pancreatic cancer remains exceedingly difficult to treat. However, the patient's primary tumor typically isn't what leads to death—it is the cancer's ability to evade ...

Oncology & Cancer

Predicting mutated gene associated with melanoma

Although risk for melanoma, the most serious type of skin cancer, is often associated with ultraviolet light exposure, genetic factors are also at play, with some families being more prone to the disease than others.

Oncology & Cancer

Reversing pancreatic cancer's gluttony

In new findings published online March 18, 2021 in the journal Cancer Cell, an international team of researchers, led by scientists at University of California San Diego School of Medicine and Moores Cancer Center, describe ...

page 33 from 40